Key Takeaways
- Resilient quarter in a weak market: Revenue held up despite summer shutdowns, erratic production schedules, and delayed EV launches across Europe and China. Diversification across customers, components, and countries absorbed regional shocks.
- Margins absorbed upfront pain, H2 recovery expected: Modules & Polymers margins fell ~130 bps as restructuring costs concentrated in Q2; management calls this one of the weakest quarters and expects improvement as compensation and pain-sharing solutions kick in during H2.
- Consumer electronics production has begun: Pilot lines are approved and shipping small volumes; a massive 500-meter Chennai plant has started construction and will take 1.5 years to reach full scale, at which point the business becomes material.
- Balance sheet positioned for distress opportunities: Leverage sits at ~1x with a target of 0.5–0.75x by March 2025; management believes it will be one of the few players with the strength to provide solutions when industry pain deepens.
- What to watch next quarter: Whether H2 production volumes actually deliver the promised margin recovery, the pace of consumer electronics ramp-up from pilot lines, and any inorganic moves as weaker competitors come under pressure.
Demand Environment & Production Headwinds
- Summer shutdowns hit Q2: Europe and other regions saw seasonal plant closures, making Q2 traditionally the weakest quarter for production volumes and working capital.
- Erratic schedules from EV uncertainty: OEMs delayed start-of-production timelines and realigned platform strategies as EV demand undershot expectations, creating unpredictable production schedules across the supply chain.
- China mix shift: Consumer preference moved between regional and international players, adding another layer of volatility for suppliers serving both segments.
- Inventory conservatism added to working capital: Management built a buffer to prevent customer disruption, but the expected September production uptick did not materialize, leaving inventory elevated entering Q3.
- Macro signals are mixed: Interest rates and inflation have stabilized, but copper prices are rising again, European energy costs are on an upward trajectory, and logistics challenges persist.
Kunal Malani: "So there is a degree of seasonality in there, but then there is a degree of conservatism, as I said, that we have built-in right now in it, which we expect to normalize as we go ahead."
Margin Trajectory & H2 Recovery
- Costs taken upfront in H1: All pain associated with the challenging environment, including restructuring and compensation agreements with customers, has been embedded in first-half results. The benefit of those pain-sharing solutions flows through only in H2.
- Modules & Polymers took the biggest hit: Margins declined ~130 bps because restructuring was concentrated in this segment; management states this was one of the weakest quarters and expects improvement moving forward.
- H2 expected better on both comparisons: Management expects H2 to beat H1 and also beat H2 of last year, driven by higher production volumes (no summer shutdowns, shorter winter shutdowns) and margin recovery from pain-sharing agreements now kicking in.
- Profit share from associates jumped: Strong performance from China and India JVs, plus a one-time gain of ~INR 70 crores from land sold to a JV and a stake buyback from Sojitz in the MASL facility, boosted the associate line both YoY and QoQ.
Consumer Electronics: The Next Growth Vector
- Production has started: Pilot lines are set up, approved, and shipping small volumes to customers; serial production is now ramping up.
- Chennai plant will be Motherson's largest globally: Construction began this month on a facility approximately 500 meters long, larger than the Alabama plant; full ramp-up takes 1.5 years, with meaningful volume impact only arriving in late FY26 or early FY27.
- JV structure with BIEL: The entire consumer electronics business, covering both component manufacturing (glass pieces) and assembly, will be a joint venture with BIEL once regulatory approval is obtained; currently held as a 100% subsidiary.
- Scale remains small for now: Management declined to provide a specific revenue run-rate, stating only that the larger plant will show the full volume impact and that the emerging businesses portfolio target is 25% of the overall mix over time.
Vivek Chaand Sehgal: "I think the largest plant of Motherson which was supposed to be in USA will be beaten by the plant which is coming up in Chennai. And just for your -- to give you an image of what kind of plant it is going to be about 500 meters long, half a kilometre and it's huge."
Balance Sheet & Capital Allocation
- Leverage to decline through H2: Working capital peaked in Q2 due to seasonal inventory build and conservatism; management expects a declining trajectory over the next six months, taking leverage from ~1x to 0.5–0.75x by March 2025, depending on production schedules.
- QIP proceeds parked for debt paydown: The INR 1,500 crores raised via CCDs in September was taken with the intent to reduce debt, because inorganic opportunities are unpredictable and the company follows a reactive strategy rather than a deal-driven one.
- Positioned as a consolidator when pain deepens: Management believes it will have one of the strongest balance sheets in the industry, which should create opportunities as weaker players struggle to provide solutions to stressed customers. No timeline can be given for inorganic moves.
- Capex guidance tightened: FY25 spend is now estimated at INR 5,000 crores ±5%, narrowed from the earlier ±10% band.
Kunal Malani: "But on a relative scale, I think we will be one of the players having the strongest balance sheet in the industry now and that should augur well, especially when pain increases and there are only few players which can actually provide solutions at that stage."
Greenfields & Organic Expansion
- 5 of 19 greenfield plants now operational: These facilities are in ramp-up phase, with another 8 expected to come online in H2 of this fiscal year.
- New Japan logistics JV: A joint venture with existing partner Hamakyorex will provide core 3PL services, EXIM, and sustainable packaging solutions to customers, starting in Japan.
- ROCE improvement expected: As aberrations normalize and the full EBIT impact of acquired businesses flows through, management anticipates further improvements in return on capital employed.
Laksh Vaaman Sehgal: "Our diversification strategy of 3CX10 helps us to mitigate regional volatilities. The diversification is further bolstered with the addition of new companies, new components, increased penetration with customers and expansion in countries."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| H2 performance | H2 better than H1 and better than H2 last year, based on current market knowledge | FY25 H2 |
| Working capital deleveraging | Leverage to decline from ~1x to 0.5–0.75x | By March 2025 |
| Capex spend | INR 5,000 crores ±5% | FY25 |
| Greenfield plants operational | 8 additional plants to commence operations | H2 FY25 |
| Modules & Polymers margin recovery | Improvement from current weak quarter | Moving forward (no date) |
| Consumer electronics at scale | Chennai plant fully up and running, showing full volume impact | ~1.5 years (late FY26 / early FY27) |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹27,800 cr, up 18% YoY |
| EBITDA | ₹2,641 cr, up 32% YoY |
| PAT (attributable to shareholders) | ₹880 cr, up 336% YoY; includes one-time fair valuation gain on acquisition |
| Consolidated ROCE (LTM basis, H1 FY25) | 17.3%, improved from 16.9% in FY24 |
| Net debt | ₹10,500 cr, vs ₹13,500 cr in Jun 2024; includes ₹1,500 cr CCDs |
| Net debt (excl. CCDs) | ₹9,000 cr |
| Net leverage | 1.0x, improved from 1.5x in Jun 2024; policy ceiling 2.5x |
| Net leverage guidance (Mar 2025) | 0.5x to 0.75x, depending on production schedules and deleveraging |
| Capex guidance (FY25) | ₹5,000 cr +/- 5%, narrowed from earlier +/- 10% |
| Greenfields operationalised | 5 of 19 in ramp-up; 8 more expected online in H2 FY25 |
| Order book | ₹8,800 cr, grown from ₹8,300–8,400 cr in Mar 2024 |
| Non-automotive revenue run-rate | ₹3,000 cr per annum |
| Automotive production decline (global, YoY) | 5% decline |
| Profit share from associates (one-time component) | ~₹70 cr from land sale to JV and Sojitz stake buy in MASL facility |